Multiple Sclerosis Research Review, Issue 40

In this issue:

Central vein sign as an MS diagnostic imaging biomarker
Association of chronic active MS lesions with disability in vivo
sNFL chain levels and long-term disease course among MS patients followed up for 12 years
Safety and efficacy of opicinumab in relapsing MS patients
Vaccination as a risk factor for MS
Cognitive and MRI assessment of MS patients coming off cannabis
Efficacy and safety of ozanimod in MS
Autoimmune nephropathies following alemtuzumab treatment in MS patients
Smoking is associated with increased disease activity during natalizumab treatment in MS
Predicting the profile of increasing disability in MS

Please login below to download this issue (PDF)